Akkermansia muciniphila and Lactobacillus plantarum ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota
mSphere · 24.08.2023 · 8 (4)
DOI: 10.1128/msphere.00070-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSphere, erschienen am 24.08.2023. Verfasst von Mengchen Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing Medical University , Nanjing, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lactiplantibacillus plantarum, Gastrointestinal Microbiome. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Key Research and Development Program of China, MOST | National Natural Science Foundation of China, Key Society development project of Jiangsu Province.
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE), characterized by persistent inflammation, is a complex autoimmune disorder that affects all organs, challenging clinical treatment. Dysbiosis of gut microbiota promotes autoimmune disorders that damage extraintestinal organs. Modulating the gut microbiome is proposed as a promising approach for fine-running parts of the immune system, relieving systematic inflammation in multiple diseases. This study demonstrated that the administration of Akkermansia muciniphila and Lactobacillus plantarum contributed to an anti-inflammatory environment by decreasing IL-6 and IL-17 and increasing IL-10 levels in the circulation. The treatment of A. muciniphila and L. plantarum restored the intestinal barrier integrity to a different extent. In addition, both strains reduced the deposit of IgG in the kidney and improved renal function significantly. Further studies revealed distinct remodeling roles of A. muciniphila and L. plantarum administration on the gut microbiome. This work demonstrated essential mechanisms of how A. muciniphila and L. plantarum remodel gut microbiota and regulate the immune responses in the SLE mice model. IMPORTANCE Several pieces of research have demonstrated that certain probiotic strains contribute to regulating excessive inflammation and restoring tolerances in the SLE animal model. More animal trials combined with clinical studies are urgently needed to further elucidate the mechanisms for the effect of specific probiotic bacteria in preventing SLE symptoms and developing novel therapeutic targets. In this study, we explored the role of A. muciniphila and L . plantarum in ameliorating the SLE disease activity. Both A. muciniphila and L. plantarum treatment relieved the systemic inflammation and improved renal function in the SLE mouse model. We demonstrated that A. muciniphila and L. plantarum contributed to an anti-inflammatory environment by regulating cytokine levels in the circulation, restoring the intestinal barrier integrity, and remodeling the gut microbiome, however, to a different extent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing Medical University , Nanjing, China.
- Department of Pathogen Biology-Microbiology Division, Nanjing Medical University , Nanjing, China.
- Department of Dermatology, The Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University , Xi'an, China.
- Zhongda Hospital, Southeast University , Nanjing, China.
- Key Laboratory of Pathogen of Jiangsu Province and Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University , Nanjing, China.
- The Laboratory Center for Basic Medical Sciences of Nanjing Medical University , Nanjing, China.
ORCID-Profile: Xingyin Liu, Zhi Liu, Qisha Liu
Förderung
- MOST | National Key Research and Development Program of China
- MOST | National Natural Science Foundation of China
- Key Society development project of Jiangsu Province
Zitieren
APA
Guo, M., Lu, M., Chen, K., Xu, R., Xia, Y., Liu, X., Liu, Z., & Liu, Q. (2023). Akkermansia muciniphila and Lactobacillus plantarum ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota. mSphere, 8(4). https://doi.org/10.1128/msphere.00070-23
Vancouver
Guo M, Lu M, Chen K, Xu R, Xia Y, Liu X, et al. Akkermansia muciniphila and Lactobacillus plantarum ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota. mSphere. 2023;8(4). doi:10.1128/msphere.00070-23
BibTeX
@article{Guo2023,
author = {Guo, Mengchen and Lu, Mei and Chen, Kun and Xu, Rui and Xia, Yumin and Liu, Xingyin and Liu, Zhi and Liu, Qisha},
title = {Akkermansia muciniphila and Lactobacillus plantarum ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota},
journal = {mSphere},
year = {2023},
volume = {8},
number = {4},
doi = {10.1128/msphere.00070-23}
}
EUVIMED